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Background
The cardiac hormone atrial natriuretic peptide (ANP)
increases intracellular cyclic GMP levels via activation of
the guanylyl cyclase-A (GC-A) receptor and exerts
important endocrine effects regulating arterial blood
pressure and intravascular volume. Besides these well-
known effects, several studies suggest a role for ANP
and its receptor in the endocrine pancreas. For instance,
ANP infusion enhanced insulin plasma levels in healthy
subjects [1]. Even more low plasma ANP levels predict
the development of diabetes type II [2]. Also it has been
shown that ANP can stimulate the function and the
growth of cultured pancreatic ß cells [3,4]. Since these
studies were conducted with synthetic ANP, the ques-
tion remains whether the endogenous ANP/GC-A sys-
tem modulates insulin secretion or the growth and
vitality of pancreatic ß cells under (patho)physiological
conditions. Therefore, here we generated and studied a
novel mouse model with conditional, cell-restricted
deletion of the GC-A receptor in cells (GC-Afl/fl;Rip-Cre
+/-: ß GC-A KO mice). The Rip-Cre mouse line was
provided by Dr. Pedro Herrera [5]. The GC-Afl/fl mice
were previously generated in our group [6].
Methods and results
Our first aim was to characterize whether ANP modu-
lates ß cell vitality and function under pathological con-
ditions of insulin resistance. Five weeks old ß GC-A KO
and control littermates were fed with a high-fat (60%
energy from fat, HFD) versus a normal diet (10% energy
from fat, ND) during 3 months. The HFD induced a
genotype-independent increase in body weight, arterial
blood pressure and fasted blood glucose levels. More-
over, all mice showed a pathological oral glucose toler-
ance test (oGTT), confirming an insulin resistant state.
In control mice, immunostainings of insulin and mor-
phometrical analyses showed an increase in the islet
area, the total area of ß cells per islet and in the number
of ß cells per islet after HFD. Since the area of single ß
cells remained the same under ND and HFD, these
results demonstrate that the observed increase in ß cell
mass was caused by ß cell proliferation and not by
hypertrophy. Strikingly, ß cell proliferation in response
to HFD-provoked insulin resistance was abolished in ß
GC-A KO mice.
As mentioned above, low plasma levels of ANP predict
development of future diabetes and glucose progression in
the elderly, suggesting a (co)causal role of deficient ANP/
GC-A signalling in diabetes development [2]. To study
whether chronic ß cell ANP/GC-A dysfunction alters
insulin-dependent glucose homeostasis, we analyzed
female ß GC-A KO and control mice at 10-15 months of
age. Fasted insulin plasma levels were not different
between genotypes. Surprisingly, the oGTT showed a bet-
ter glucose handling in the ß GC-A KO mice, with lower
plasma glucose levels at all time-points and a significantly
lower area under the curve (AUC). Insulin sensitivity was
not different between genotypes. However, glucose-stimu-
lated insulin release was enhanced in the ß GC-A KO
mice.
Conclusions
Our data indicate that ANP/GC-A signalling contributes
to enhanced b-cell proliferation in situations of insulin
resistance, for instance under HFD. The molecular
mechanism of the improved glucose-dependent insulin
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secretion in the older ß GC-A KO mice is being
addressed in our current investigations. Our study con-
tributes to the recent appreciation of the metabolic roles
of ANP and suggests an endocrine axis between the
heart and the endocrine pancreas.
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